1415226-40-2 Usage
Description
5-(3-chlorophenyl)-3-hydroxypyridine-2-carboxylic acid is a chemical compound with a molecular formula C12H8ClNO3. It is a derivative of pyridine-2-carboxylic acid, featuring a hydroxyl group and a chlorine atom attached to the phenyl ring. 5-(3-chlorophenyl)-3-hydroxypyridine-2-carboxylic acid possesses potential pharmacological properties and has been investigated for its anti-inflammatory and anti-bacterial activities.
Uses
Used in Pharmaceutical Industry:
5-(3-chlorophenyl)-3-hydroxypyridine-2-carboxylic acid is used as a pharmaceutical intermediate for the development of new drugs due to its potential pharmacological properties. Its anti-inflammatory and anti-bacterial activities make it a promising candidate for the treatment of various conditions.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 5-(3-chlorophenyl)-3-hydroxypyridine-2-carboxylic acid serves as a key compound for further research and development. Scientists are exploring its potential uses and optimizing its structure to enhance its therapeutic effects and safety profile.
Check Digit Verification of cas no
The CAS Registry Mumber 1415226-40-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,1,5,2,2 and 6 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1415226-40:
(9*1)+(8*4)+(7*1)+(6*5)+(5*2)+(4*2)+(3*6)+(2*4)+(1*0)=122
122 % 10 = 2
So 1415226-40-2 is a valid CAS Registry Number.
1415226-40-2Relevant articles and documents
MANUFACTURING PROCESS FOR 3,5-DICHLOROPICOLINONITRILE FOR SYNTHESIS OF VADADUSTAT
-
, (2022/01/12)
Disclosed herein are methods and processes of preparing vadadustat or a pharmaceutically acceptable salts thereof, and intermediates (e.g., a compound of Formula (I), (I-F), (II), or (IV), or a pharmaceutically acceptable salts thereof) useful for the syn
DEUTERIUM-ENRICHED HYPOXIA-INDUCIBLE FACTOR PROLYL HYDROXYLASE ENZYME INHIBITORS
-
, (2016/10/11)
Provided herein are deuterium-enriched compounds of Formula (I), Formula (II), Formula (III), Formula (IV), Formula (V), and Formula (VI). Pharmaceutical compositions comprising the isotope-enriched compounds, and methods of using such compounds are also provided.
